Frances Lee, MD, on stigma's role in ALD care and why women may progress to advanced disease faster than men.
News|Videos|May 8, 2026
5 Hepatology Headlines You Missed in April 2026
Author(s)Abigail Brooks, MA
Fact checked by: Alex Hillenbrand
Catch up on updates in viral hepatitis treatment, advances in rare liver disease care, and more.
Advertisement
Advertisement
April brought a series of important developments in hepatology, with advances in chronic viral hepatitis, rare cholestatic liver diseases, and precision medicine continuing to shape the field. From regulatory momentum in
Related to this article
Frances Lee, MD, on the stigma driving under-detection of ALD and its disproportionate rise in women and younger adults.
BEACON-HCC offers a new approach to HCC treatment allocation, with key differences from the updated BCLC framework.
George Vasquez-Rios, MD, explains how the ASN's GD-C Compendium curates glomerular disease guidance for general clinicians and specialists alike.
Andrew Cutler, MD, says real-world MDD patients respond to adjunctive cariprazine like trial participants, with gains in mood and function within weeks.
SOCS leaders explain SOCS Serves, a toolkit-based program connecting dermatology volunteers with students and underserved communities.
EMBARQ-CSU1 and EMBARQ-CSU2 showed sustained reductions in urticaria, with the antibody meeting all primary and key secondary endpoints at Week 12.
The FDA-approved update adds phase 3 HYPERION data on adults diagnosed with PAH within the past year.
Advertisement
Advertisement